Volume 17, Number 6—June 2011
Research
Invasive Group A Streptococcal Infection and Vaccine Implications, Auckland, New Zealand
Table 3
Diagnosis† | Age group, y |
All ages, no. (%),‡ N = 225 | p value§ | ||||
---|---|---|---|---|---|---|---|
0–14, n = 36 |
>15, n = 189 |
||||||
No. | CFR | No. | CFR | ||||
Skin and soft tissue infection¶ | 11 | 0 | 86 | 8 | 97 (43) | 0.14 | |
Bacteremia only | 7 | 38 | 31 | 19 | 38 (16) | 0.63 | |
STSS#** | 6 | 67†† | 24 | 54 | 30 (13) | 0.59 | |
Bone infection | 6 | 0 | 20 | 0 | 26 (12) | 0.39 | |
Pneumonia and other respiratory infection | 12 | 13 | 12 | 0 | 24 (11) | 0.0001 | |
Necrotizing fasciitis** | 1 | 0 | 19 | 15 | 20 (9) | 0.21 | |
Pelvic infection/peripartum‡‡ | 0 | 0 | 12 | 0 | 12 (5) |
*CFR, case-fatality rate; GAS, group A streptococcal; STSS, streptococcal toxic shock syndrome.
†Patients may have had >1 diagnosis, with the exception of bacteremia without a source. Other conditions (not shown) included 4 upper airway infections 6 ear/nose/throat infections, 5 central nervous system infections, 4 cases of peritonitis, 3 urinary tract infections, and 2 hemodialysis vascular access infections. No deaths occurred in this group.
‡Overall CFR 10% (22/225).
§p value calculated by using Fisher exact test, a test of difference between age groups.
¶Includes cellulitis (n = 79), cutaneous abscess, boil, lymphadenitis, myositis, bursitis, infected burn, infected scabies, and infected ulcer with evidence of documented bacteremia.
#STSS confirmed and probable (n = 3).
**Five patients had STSS and NF; 1/5 died (20% CFR).
††Three of 6 were community deaths in infants <1 y of age.
‡‡Includes pregnancy-related (n = 6) endometritis and infected products, urinary tract infection/chorioamnionitis, and wound problems.